PIGEON CORP/ADR (OTCMKTS:PGENY) versus NIHON KOHDEN CO/ADR (OTCMKTS:NHNKY) Financial Review

Share on StockTwits

NIHON KOHDEN CO/ADR (OTCMKTS:NHNKY) and PIGEON CORP/ADR (OTCMKTS:PGENY) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability and risk.

Volatility and Risk

NIHON KOHDEN CO/ADR has a beta of -0.28, indicating that its share price is 128% less volatile than the S&P 500. Comparatively, PIGEON CORP/ADR has a beta of 0.43, indicating that its share price is 57% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and target prices for NIHON KOHDEN CO/ADR and PIGEON CORP/ADR, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NIHON KOHDEN CO/ADR 0 0 0 0 N/A
PIGEON CORP/ADR 1 0 0 0 1.00

Dividends

NIHON KOHDEN CO/ADR pays an annual dividend of $0.11 per share and has a dividend yield of 0.8%. PIGEON CORP/ADR pays an annual dividend of $0.12 per share and has a dividend yield of 1.3%. PIGEON CORP/ADR pays out 44.4% of its earnings in the form of a dividend.

Insider & Institutional Ownership

0.0% of NIHON KOHDEN CO/ADR shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares NIHON KOHDEN CO/ADR and PIGEON CORP/ADR’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
NIHON KOHDEN CO/ADR $1.57 billion 1.53 $82.38 million N/A N/A
PIGEON CORP/ADR $950.58 million 4.79 $129.57 million $0.27 35.19

PIGEON CORP/ADR has lower revenue, but higher earnings than NIHON KOHDEN CO/ADR.

Profitability

This table compares NIHON KOHDEN CO/ADR and PIGEON CORP/ADR’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
NIHON KOHDEN CO/ADR N/A N/A N/A
PIGEON CORP/ADR 12.16% 18.98% 14.62%

Summary

PIGEON CORP/ADR beats NIHON KOHDEN CO/ADR on 8 of the 11 factors compared between the two stocks.

NIHON KOHDEN CO/ADR Company Profile

Nihon Kohden Corp. engages in the medical electronic equipment business. Its products include electrocardiograph, electroencephalograph, evoked potential/EMG, sleep diagnostic, patient monitoring, hematology, hemostasis, ventilation products, and others. The company was founded by Yoshio Ogino on August 7, 1951 and is headquartered in Tokyo, Japan.

PIGEON CORP/ADR Company Profile

Pigeon Corporation manufactures, sells, imports, and exports baby and child-care products, maternity items, women's care products, home healthcare products, elder care products, etc. in Japan and internationally. The company operates through Domestic Baby & Mother Care Business, Child Care Service Business, Health & Elder Care Business, Overseas Business, China Business, and Other segments. It offers breastfeeding, weaning, skincare, women's care, and large-sized products for babies, as well as other products for babies and mothers. The company also provides child-rearing support, babysitter dispatch, event child-care, and preschool education services; and operates child-minding facilities and daycare centers. In addition, it offers elder care and anti-aging products, and elder care support services; and baby and mother related products, such as nursing bottles and nipples, toiletries, and skincare products. The company was formerly known as Pigeon Honyuki Honpo Corporation and changed its name to Pigeon Corporation in 1966. Pigeon Corporation was founded in 1949 and is headquartered in Tokyo, Japan.

Receive News & Ratings for NIHON KOHDEN CO/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NIHON KOHDEN CO/ADR and related companies with MarketBeat.com's FREE daily email newsletter.